Search clinical trials for: Oseltamivir, amantidine, Symmetrel, Tamiflu

Total 77 results

Weill Medical College of Cornell University
Genentech, Inc.

Recruiting

Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza

Influenza

United States
Tongji Hospital

Recruiting

Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients

ST Elevation Myocardial Infarction | STEMI

China
University of Oxford
Bill and Melinda Gates Foundation; Department for International Development... and other collaborators

Recruiting

Randomised Evaluation of COVID-19 Therapy (RECOVERY)

Severe Acute Respiratory Syndrome

Ghana, Indonesia, Nepal, South Africa, United Kingdom, Vietnam, India
SpringWorks Therapeutics, Inc.

Active, not recruiting

Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) (DeFi)

Desmoid Tumor | Aggressive Fibromatosis

United States, Belgium, Germany, Canada, Italy, Netherlands, United Kingdom
SpringWorks Therapeutics, Inc.

Available

Individual Patient Compassionate Use of Nirogacestat

Desmoid Tumor | NOTCH Gene Mutation Positive Tumors
University of Louisville
Centers for Disease Control and Prevention

Completed

Rapid Empiric Treatment With Oseltamivir Study (RETOS) (RETOS)

Pneumonia | Influenza

United States
University of Washington
Genentech, Inc.

Terminated

Test-and-treat for Influenza in Homeless Shelters

Influenza | Respiratory Viral Infection

United States
The Affiliated Hospital of Qingdao University

Completed

Study on the Human Bioequivalence of Oseltamivir Phosphate For Oral Suspension

Healthy Subjects

China
University Medical Centre Ljubljana

Completed

Prophylactic Treatment With Oseltamivir

Influenza, Human

Slovenia
Unity Health Toronto
University of Toronto; Li Ka Shing Knowledge Institute

Unknown

Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia

Immune Thrombocytopenia

Canada
Austarpharma, LLC

Unknown

Bioequivalence Study of Oseltamivir Phosphate and TAMIFLU Under Fed Condition in Healthy Volunteers

Bioequivalence

United States
Hoffmann-La Roche

Completed

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Influenza

United States, Denmark, Canada
Materia Medica Holding

Completed

Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

Influenza

Russian Federation
Shionogi

Completed

Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications (CAPSTONE 2)

Influenza
The University of Hong Kong

Completed

Treatment of Severe Influenza A Infection

Influenza, Human

Hong Kong
Johns Hopkins University
Department of Health and Human Services

Completed

ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir

Influenza

United States
University of Manitoba
Hoffmann-La Roche

Withdrawn

Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit

Influenza A Virus Infection | Influenza B Virus Infection

Canada
Shionogi

Completed

A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza (CAPSTONE 1)

Influenza
MedImmune LLC

Withdrawn

Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.

Influenza - Type A Strains
McMaster University

Withdrawn

An RCT of Oseltamivir in Outpatients With CPD: A Pilot Study. (AVT)

Influenza | Pulmonary Disease
Hoffmann-La Roche

Completed

A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection

Influenza

United States, Spain, Belgium, Canada, Colombia, Germany, Israel, Poland, Brazil, Chile, Finland, Greece, Italy, Mexico, South Africa
Marshfield Clinic Research Foundation
Centers for Disease Control and Prevention

Completed

Efficacy Study of Early Versus Late Oseltamivir Administration for Treating and Preventing Influenza

Influenza

United States
GlaxoSmithKline

Completed

A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza (ZORO)

Influenza, Human

Australia, Taiwan, Korea, Republic of, United States, Belgium, Canada, Germany, South Africa, Spain, United Kingdom, New Zealand, Thailand, India, China, Brazil, Hong Kong, Slovakia, Russian Federation, Denmark, Mexico, Czechia, H... and more
Hoffmann-La Roche

Completed

A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.

Influenza, Human

United States, Spain, Belgium, Poland, Germany, United Kingdom, Chile, Estonia, Hungary, Italy, France, South Africa, Mexico, Israel, Brazil, Guatemala, Czechia, Lithuania, Argentina, Bulgaria, Canada, Colombia, Latvia, Romania, Switzer... and more
University of Oxford
South East Asia Infectious Disease Clinical Research Network

Completed

Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand

Metabolic Disease

Thailand
Genentech, Inc.

Completed

A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection

Influenza

Spain, United Kingdom, Korea, Republic of, Belgium, Czechia, Canada, Netherlands, Hong Kong, New Zealand, Peru, Germany, France, Israel, Hungary, South Africa, Sweden, Mexico, Taiwan, Brazil, Bulgaria, Chile, Italy, Poland, Russian Federation and more
Romark Laboratories L.C.

Completed

Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

Influenza

United States, Australia, Belgium, Canada, New Zealand
McMaster University
University of Alberta; University of Calgary

Terminated

A Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With Influenza

Influenza

Canada
National Institute of Allergy and Infectious Diseases...

Completed

Alternative Oseltamivir Dosing Strategies

Influenza

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers

Influenza, Human

United States
Hoffmann-La Roche

Completed

A Pharmacokinetic/Pharmacodynamic (PK/PD) and Safety Evaluation of Oseltamivir [Tamiflu] in the Treatment of Infants 0 to <12 Months of Age With Confirmed Flu Infection

Influenza

Belgium, Poland, France, Germany, Italy, Spain
Genentech, Inc.

Completed

A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model

Healthy Volunteer

United Kingdom
Trial Management Group Inc.
Hoffmann-La Roche

Completed

Effect of Oseltamivir on Cognitive Function in Subjects With Influenza (FOCUS)

Influenza

Canada
Hoffmann-La Roche

Terminated

A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.

Influenza

Italy
Manjunath Prakash Pai
Hoffmann-La Roche

Completed

Pharmacokinetics of Oseltamivir Carboxylate In Morbidly Obese Subjects

Obesity

United States
Hoffmann-La Roche

Completed

A Pharmacokinetics, Pharmacodynamics and Safety Study of Warfarin in Combination With Tamiflu (Oseltamivir)

Drug Therapy, Combination

United Kingdom
Hanmi Pharmaceutical Company Limited

Completed

Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions

Healthy

Korea, Republic of
Hoffmann-La Roche

Completed

Influenza Resistance Information Study (IRIS)

Influenza

Australia, Hong Kong, United States, France, Germany, Netherlands, Norway, Poland
Hanmi Pharmaceutical Company Limited

Completed

Evaluating the Bioequivalence of HIP1403, HGP0919

Healthy

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

Influenza

United States, Lebanon, Israel
Hoffmann-La Roche

Completed

A Pharmacokinetic Study on Co-administration of Tamiflu (Oseltamivir) and Rimantadine in Healthy Volunteers

Healthy Volunteer

United States
Hoffmann-La Roche

Completed

A Study on Emergence of Resistance With Oseltamivir (Tamiflu) in Participants With Seasonal Influenza

Influenza

Brazil
Hoffmann-La Roche

Terminated

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Influenza

United States, Israel
Hoffmann-La Roche

Completed

A Single Dose Study of Tamiflu in Volunteers in Dialysis And in Volunteers With Reduced Creatinine Clearance

Healthy Volunteer

New Zealand
Hoffmann-La Roche

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oseltamivir and Its Carboxylate Metabolite, RO0640802 in Healthy Participants

Healthy Volunteer

United States
Hoffmann-La Roche

Completed

A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants

Influenza

Belgium, Israel, Italy, Spain, United States, Germany, Canada, France, Estonia, Poland, Hungary, Lithuania, United Kingdom, Czech Republic
The First Affiliated Hospital of Guangzhou Medical...

Unknown

Lingdancao Granules in the Treatment of Seasonal Influenza

Influenza
Hoffmann-La Roche

Completed

A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD)

End Stage Renal Disease

New Zealand
University of Pittsburgh
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Withdrawn

A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy

Pregnancy | Influenza

United States
Genuine Research Center, Egypt
Pharmacare PLC, Palestine

Completed

A Bioequivalence Study of Oseltamivir From Oseltamivir 75 mg Caps (Pharmacare PLC, Palestine) and Tamiflu® 75 mg Caps (Hoffmann-La Roche, Switzerland)

Healthy

Egypt

Search clinical trials for: Oseltamivir, amantidine, Symmetrel, Tamiflu

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations